Table 3 The impact of COVID-19 on the stroke outcomes
Groups | Covid-19 | Control | P-value |
|---|---|---|---|
(N = 77) | (N = 322) | ||
Variables | Number (%), Median (Range) | Number (%), Median (Range) | |
NIHSS | 7 (0–42) | 12 (1–42) | 0.906 |
IQR | 8.5 | 11 | |
mRS > 2 | 50 (64.93%) | 133 (41.3%) | 0.001 |
In-hospital death | 9 (11.7%) | 13(4.04%) | 0.02 |
Respiratory failure | 4 (5.19%) | 0 (0%) | |
Sepsis | 0 (0%) | 5 (1.55%) | |
Aspiration pneumonia | 0 (0%) | 2 (0.62%) | |
Pulmonary embolism | 3 (3.89%) | 2 (0.62%) | |
Myocardial infarction | 0 (0%) | 1 (0.31%) | |
Acute kidney injury | 2 (2.59%) | 0 (0%) |